Željko Antić
Impact in
-
- Acute Lymphoblastic Leukemia research
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Acute Lymphoblastic Leukemia research 18
-
- Acute Myeloid Leukemia Research 1
- Co-authors
- Edwin Sonneveld (5 shared papers)Roland P. Kuiper (5 shared papers)Peter M. Hoogerbrugge (4 shared papers)Esmé Waanders (3 shared papers)Marta F. Fiocco (2 shared papers)Ad Geurts van Kessel (2 shared papers)Rob Pieters (2 shared papers)Simon V. van Reijmersdal (3 shared papers)
- Journals
- Blood (4 papers)Leukemia (3 papers)HemaSphere (2 papers)Best Practice & Research Clinical Haematology (2 papers)Pediatric Blood & Cancer (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Željko Antić
17 papers receiving 325 citations
Peers
Comparison fields: 5 of 24
- Public Health, Environmental and Occupational Health 251
- Hematology 38
- Cancer Research 19
- Health Informatics 2
- Oncology 8
Countries citing papers authored by Željko Antić
This map shows the geographic impact of Željko Antić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Željko Antić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Željko Antić more than expected).
Fields of papers citing papers by Željko Antić
This network shows the impact of papers produced by Željko Antić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Željko Antić. The network helps show where Željko Antić may publish in the future.
Co-authors
The 25 scholars most cited alongside Željko Antić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 121 | |
| 2 | 2021 | 67 | |
| 3 | 2023 | 36 | |
| 4 | 2020 | 17 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 12 | |
| 7 | 2024 | 11 | |
| 8 | 2021 | 10 | |
| 9 | 2024 | 10 | |
| 10 | 2020 | 7 | |
| 11 | 2017 | 5 | |
| 12 | 2024 | 5 | |
| 13 | 2020 | 4 | |
| 14 | 2024 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2025 | 2 | |
| 17 | 2022 | 1 | |
| 18 | 2023 | 0 |
About Željko Antić
Željko Antić is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Genetics, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 18 papers that have together received 326 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (18 papers), Genomic variations and chromosomal abnormalities (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Public Health, Environmental and Occupational Health (251 citations), Hematology (38 citations), Cancer Research (19 citations), Health Informatics (2 citations) and Oncology (8 citations). Željko Antić has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Edwin Sonneveld, Roland P. Kuiper, Peter M. Hoogerbrugge, Esmé Waanders, Marta F. Fiocco, Ad Geurts van Kessel, Rob Pieters, Simon V. van Reijmersdal, Jiangyan Yu and Frank N. van Leeuwen. Their work appears in journals such as Blood, Leukemia, HemaSphere, Best Practice & Research Clinical Haematology and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.